MitoImmune Therapeutics
PrivateLast Round
Series B
Extension
Sep 25, 2023
Total Funding Raised
$38.81M
Company Overview
MitoImmune Therapeutics is a biotechnology company that develops innovative drugs targeting mitochondrial dysfunction and regulated necrotic cell death.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MitoImmune Therapeutics Comparables
Compare MitoImmune Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Morningside | 78% | |
| SeaBeLife | 77% | |
| Pretzel Therapeutics | 77% | |
MitoImmune Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Sep 25, 2023 | ||||
| Series B | Feb 26, 2021 | ||||
| Series A | Apr 1, 2019 |
MitoImmune Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BNH INVESTMENT | Series A, Series B |
| SL Investment | Series A, Series B |
| KB Investment | Series A, Series B |
| Orion Capital Management | Series B |
| K-Ground Ventures | Series B Extension |
| GTO Investment | Series B |
| CJ Investment | Series B |
MitoImmune Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MitoImmune Therapeutics's valuation, stock price, and market status.